Sign in
SCHEDULE 13D/A

Beneficial Ownership Report

Spero Therapeutics, Inc. Filed Acc 0001999371-25-003391

Stakes reported in this filing

Reporting person Shares Of the class
GSK PLC 9,190,606 16.4%

Members of a group can each report the same shares, so these rows overlap and don't add up.

Loading xslSCHEDULE_13D_X01/primary_doc.xml…